BlackRock Institutional Trust’s Strata Skin Sciences SSKN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$142K Hold
6,453
﹤0.01% 3617
2016
Q3
$171K Hold
6,453
﹤0.01% 3635
2016
Q2
$197K Hold
6,453
﹤0.01% 3637
2016
Q1
$305K Hold
6,453
﹤0.01% 3547
2015
Q4
$358K Hold
6,453
﹤0.01% 3560
2015
Q3
$368K Hold
6,453
﹤0.01% 3554
2015
Q2
$371K Buy
6,453
+1,051
+19% +$85.6K ﹤0.01% 3553
2015
Q1
$694K Buy
5,402
+369
+7% +$36.4K ﹤0.01% 3437
2014
Q4
$302K Sell
5,033
-252
-5% -$20.7K ﹤0.01% 3594
2014
Q3
$454K Hold
5,285
﹤0.01% 3507
2014
Q2
$849K Buy
5,285
+98
+2% +$22.2K ﹤0.01% 3478
2014
Q1
$1.62M Buy
5,187
+839
+19% +$295K ﹤0.01% 3254
2013
Q4
$1.39M Buy
4,348
+516
+13% +$185K ﹤0.01% 3290
2013
Q3
$1.4M Sell
3,832
-15
-0.4% -$6K ﹤0.01% 3270
2013
Q2
$1.79M Buy
+3,847
New +$2.06M ﹤0.01% 3142

Other funds holding SSKN

BlackRock Institutional Trust's SSKN Position: Q4 2016 in Review

BlackRock Institutional Trust held its Strata Skin Sciences (SSKN) position steady in Q4 2016 at 6,453 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #3617.

BlackRock Institutional Trust first reported a position in SSKN in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.79M in Q2 2013. 25 funds tracked by Wall St. Rank hold SSKN as of Q4 2016.

  • BlackRock Institutional Trust held 6,453 shares of Strata Skin Sciences worth $142K as of Q4 2016.
  • BlackRock Institutional Trust left its Strata Skin Sciences share count unchanged in Q4 2016.
  • Strata Skin Sciences made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3617 holding.
  • BlackRock Institutional Trust first reported a position in Strata Skin Sciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Strata Skin Sciences position peaked at $1.79M in Q2 2013.
  • 25 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.